Effect of chronic administration of aqueous extract of Neem (Azadirachta indica) leaves on Paracetamol-induced hepatotoxicity in Wistar albino rats
-
Published:2022-12-31
Issue:
Volume:
Page:
-
ISSN:2619-9645
-
Container-title:Current Perspectives on Medicinal and Aromatic Plants (CUPMAP)
-
language:en
-
Short-container-title:CUPMAP
Author:
BHARALİ Pranob Jyoti1, BORDOLOİ Sushanta Kumar2, DAS Swarnamoni2, LAHON Kingshuk3
Affiliation:
1. Biopharmaceuticals R&D, Respiratory & Immunology, AstraZeneca India 2. Assam Medical College, Dibrugarh, Assam, India 3. Veer Chandra Singh Garhwali Govt. Institute of Medical Science & Research, Srinagar Garhwal, Uttarakhand-246174, India
Abstract
Hepatoprotective drugs are not available for use in modern medicine and different parts of medicinal plants like Neem (Azadirachta indica) are used as hepatoprotectants in traditional medicine. Although there are scientific reports of its hepatoprotective activity on acute administration, we found only one study which had evaluated its hepatoprotective effect on chronic administration. Objectives: To evaluate the effect of chronic oral administration of Neem on paracetamol-induced hepatotoxicity in Wistar rats. Methods: We randomly assigned 72 male and female Wistar albino rats to four groups of 18 animals each and orally administered Distilled water 5ml/kg body weight/day to Groups A (Normal control) and B (Experimental control), 500 mg/kg aqueous Neem leaf extract (Test) to Group C and Silymarin suspension (Standard) 100mg/kg/day to Group D for 30 days. On the 8th day, we induced hepatotoxicity with Paracetamol 2g/kg body weight single dose to groups B, C and D. We performed liver function tests, recorded liver weights and examined liver histology of six rats from each group on 10th, 20th and 30th days. Results: We observed significant difference (P
Publisher
Current Perspectives on Medicinal and Aromatic Plants (CUPMAP)
Subject
Materials Science (miscellaneous)
Reference116 articles.
1. Ramadori, G., Moriconi, F., Malik, I., and Dudas J., (2008). Physiology and pathophysiology of liver inflammation, damage and repair. Journal of Physiology and Pharmacology, Aug;59 Suppl 1:107-117. PMID: 18802219. 2. Mansour, H.H., Hafez, H.F., and Fahmy, N.M., (2006). Silymarin modulates Cisplatin-induced oxidative stress and hepatotoxicity in rats. Journal of Biochemistry and Molecular Biology, Nov 30,39(6),656-661. doi: 10.5483/bmbrep.2006.39.6.656. PMID: 17129399. 3. Camini, FC., and Costa, DC., (2020). Silymarin: not just another antioxidant. Journal of Basic and Clinical Physiology and Pharmacology, 2020 Mar 5,31(4)/j/jbcpp.2020.31.issue-4/jbcpp-2019-0206/jbcpp-2019-0206.xml. doi: 10.1515/jbcpp-2019-0206. PMID: 32134732. 4. Polyak, SJ., Ferenci, P., and Pawlotsky, JM., (2013). Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection. Hepatology, 57(3),1262-1271. doi: 10.1002/hep.26179. PMID: 23213025; PMCID: PMC3594650. 5. Bedi, O., Bijjem, KRV., Kumar, P., and Gauttam, V., (2016). Herbal Induced Hepatoprotection and Hepatotoxicity: A Critical Review. Indian Journal of Physiology and Pharmacology,60(1),6-21. PMID: 29953177.
|
|